U-MCE
Summary of public USPTO data
- Owner
- LTZ Therapeutics Inc.
- Status
- Live/Registered
- Serial number
- 99104766
- Registration number
- 8371719
- Filing date
- 2025-03-26
- Registration date
- 2026-07-28
- International classes
- 5, 42
Goods and services
Class 5
- Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer
- Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes
- Diagnostic preparations for medical purposes
- Diagnostic biomarker reagents for medical purposes
- Immunostimulants
- Pharmaceutical preparations for the treatment of immune system related diseases and disorders
- Tumor suppressing agents
- Pharmaceutical products for the prevention and treatment of cancer
- Biological preparations for the treatment of cancer
Class 42
- Technical research in the field of pharmaceutical studies
- Research and development of new products for others
- Pharmaceutical product evaluation
- Research and development services of new pharmaceutical products
- Biological research
- Research and development services in the field of immunology
- Providing scientific research information in the field of pharmaceuticals
- Conducting early evaluations in the field of new pharmaceuticals
- Research and development services in the field of antibodies